These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11606364)
1. A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Iughetti P; Suzuki O; Godoi PH; Alves VA; Sertié AL; Zorick T; Soares F; Camargo A; Moreira ES; di Loreto C; Moreira-Filho CA; Simpson A; Oliva G; Passos-Bueno MR Cancer Res; 2001 Oct; 61(20):7375-8. PubMed ID: 11606364 [TBL] [Abstract][Full Text] [Related]
2. D104N polymorphism in endostatin, an angiogenesis inhibitor, in acute and chronic myeloid leukaemia. Nascimento H; Lourenço GJ; Ortega MM; Yamaguti GG; Costa FF; Lima CS Leuk Res; 2007 Aug; 31(8):1158-9. PubMed ID: 17067672 [No Abstract] [Full Text] [Related]
3. [Endostatin--light on the treatment of cancer in mice]. Porkka K Duodecim; 1997; 113(22):2241-3. PubMed ID: 10892128 [No Abstract] [Full Text] [Related]
4. Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study. Mucci LA; Stark JR; Figg WD; Schumacher F; Li H; Abe M; Hennessy K; Stampfer MJ; Gaziano JM; Ma J; Kantoff PW Int J Cancer; 2009 Sep; 125(5):1143-6. PubMed ID: 19431146 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo. Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Wu P; Yonekura H; Li H; Nozaki I; Tomono Y; Naito I; Ninomiya Y; Yamamoto H Biochem Biophys Res Commun; 2001 Nov; 288(5):1149-54. PubMed ID: 11700031 [TBL] [Abstract][Full Text] [Related]
7. [The role of endostatin in tumor growth and progression of atherosclerosis]. Zhu JJ; Gao W; Chen GH Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):243-5. PubMed ID: 12545714 [No Abstract] [Full Text] [Related]
8. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer. Beck MT; Chen NY; Franek KJ; Chen WY Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947 [TBL] [Abstract][Full Text] [Related]
9. Collagen type XVIII/endostatin is differentially expressed in primary and metastatic colorectal cancers and ovarian carcinomas. Guenther U; Herbst H; Bauer M; Isbert C; Buhr HJ; Riecken EO; Schuppan D Br J Cancer; 2001 Nov; 85(10):1540-5. PubMed ID: 11720442 [TBL] [Abstract][Full Text] [Related]
10. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381 [TBL] [Abstract][Full Text] [Related]
12. Cancer therapy. Setbacks for endostatin. Marshall E Science; 2002 Mar; 295(5563):2198-9. PubMed ID: 11910086 [No Abstract] [Full Text] [Related]
13. Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in prostate [corrected] cancer. Li HC; Cai QY; Shinohara ET; Cai H; Cao C; Wang ZF; Teng M; Zheng W; Lu B Dis Markers; 2005; 21(1):37-41. PubMed ID: 15735323 [TBL] [Abstract][Full Text] [Related]
14. NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Xu R; Yao ZY; Xin L; Zhang Q; Li TP; Gan RB Biochem Biophys Res Commun; 2001 Nov; 289(1):264-8. PubMed ID: 11708810 [TBL] [Abstract][Full Text] [Related]
15. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities. Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068 [TBL] [Abstract][Full Text] [Related]
16. Genotyping and functional analysis of the D104N variant of human endostatin. Macpherson GR; Singh AS; Bennett CL; Venzon DJ; Liewehr DJ; Franks ME; Dahut WL; Kantoff PW; Price DK; Figg WD Cancer Biol Ther; 2004 Dec; 3(12):1298-303. PubMed ID: 15662127 [TBL] [Abstract][Full Text] [Related]
17. A polymorphism in the angiogenesis inhibitor, endostatin, in sporadic colorectal adenocarcinoma. Nascimento H; Rodrigues Coy CS; Navarro Góes JR; Ferreira Costa F; Passos Lima CS Int J Colorectal Dis; 2004 Sep; 19(5):499-501. PubMed ID: 15083322 [No Abstract] [Full Text] [Related]
18. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567 [TBL] [Abstract][Full Text] [Related]
19. Endostatin gene variation and protein levels in breast cancer susceptibility and severity. Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451 [TBL] [Abstract][Full Text] [Related]
20. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Li X; Fu GF; Fan YR; Liu WH; Liu XJ; Wang JJ; Xu GX Cancer Gene Ther; 2003 Feb; 10(2):105-11. PubMed ID: 12536198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]